|| HAZARDOUS - Potential
Refer to the AHS Hazardous Medication Handling Guide for more information.
Prepare in a biological safety cabinet using aseptic technique whenever possible.
1. Weigh the cream/ vehicle base.
2. Backload cream base into a disposable 60 mL syringe.
3. Place the syringe into a hood.
4. Withdraw the desired amount of cidofovir into another disposable 60 mL syringe.
5. Attach a luer lock-to–leur lock connector to the syringe.
6. Connect the syringe containing cream base to the connector.
7. Inject the contents of the syringes back and forth between the two syringes until the cream base is thoroughly mixed with the cidofovir solution and the mixture is smooth and consistent in texture.
8. Detach the connector and transfer the mixture to a clean jar.
||Cidofovir 75 mg/mL injection is available through Health Canada's Special Access Program.
The syringe method of preparation is ideal when the amount of cream or gel compounded is usually less than 40 g.
NOTE: Velvachol, Pentravan (Gallipot), Dermovan or a propylene glycol-based jelly can be used instead of Eucerin.
|| Ointment Jar
||For External Use Only|
||Hazardous medication - use safe handling precautions
||Protect From Light
||Store at Room Temperature
|Storage/Expiry:||Room Temperature: 30 days|
|Last Date Revised:
|References:|| AHS Hazardous Medication Handling information available on Insite: http://insite.albertahealthservices.ca/17382.asp|
National Institute of Health Clinical Center Pharmacy Department Dr. Bethseda MD 20892 301-496-4363. (Received December 27, 2012 from Jae Kim compounding pharmacist).
Toro JR, et al. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. Arch Dermatol 2000; 136(8): 983-985.
Velasco AA, et al. Topical cidofovir for the treatment of resistant viral infections: a case report. EJHP Science 2009; 15(4): 83-85.
McElhiney LF. Topical cidofovir: for treatment of resistant viral infections. International Journal of Pharmaceutical Compounding 2006 (Sept/Oct); 10(5): 324-328.